SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jianjian Ji, Jingjing Xu, Fanlin Li, Xiaojing Li, Wei Gong, Yuxian Song, Huan Dou, Yayi Hou, A benzenediamine derivate FC-99 attenuates lupus nephritis in MRL/lprmice via inhibiting myeloid dendritic cell-secreted BAFF, Acta Biochimica et Biophysica Sinica, 2016, 48, 5, 411

    CrossRef

  2. 2
    Yong Du, Chandra Mohan, Systemic Lupus Erythematosus, 2016,

    CrossRef

  3. 3
    Nuoyan Zheng, Donxian Wang, Hongyan Ming, Haiqing Zhang, Xueqing Yu, BAFF promotes proliferation of human mesangial cells through interaction with BAFF-R, BMC Nephrology, 2015, 16, 1

    CrossRef

  4. 4
    Hironari Hanaoka, Yuko Kaneko, Masataka Kuwana, Tsutomu Takeuchi, Early achievement of complete renal response predicts good long-term renal outcome and low systemic damage in newly diagnosed lupus nephritis class III or IV, Modern Rheumatology, 2015, 25, 5, 714

    CrossRef

  5. 5
    I. Parodis, A. Zickert, B. Sundelin, M. Axelsson, J. Gerhardsson, E. Svenungsson, V. Malmstrom, I. Gunnarsson, Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy, Lupus Science & Medicine, 2015, 2, 1, e000061

    CrossRef

  6. 6
    Anne Davidson, Ramalingam Bethunaickan, Celine Berthier, Ranjit Sahu, Weijia Zhang, Matthias Kretzler, Molecular studies of lupus nephritis kidneys, Immunologic Research, 2015, 63, 1-3, 187

    CrossRef

  7. 7
    Timothy A. Gottschalk, Evelyn Tsantikos, Margaret L. Hibbs, Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus Erythematosus, Frontiers in Immunology, 2015, 6,

    CrossRef

  8. 8
    Naomi I Maria, Petra Vogelsang, Marjan A Versnel, The clinical relevance of animal models in Sjögren’s syndrome: the interferon signature from mouse to man, Arthritis Research & Therapy, 2015, 17, 1

    CrossRef

  9. 9
    Yacong Zhao, Xiafei Hao, Jiannan Feng, Beifen Shen, Jing Wei, Jian Sun, The comparison of BLyS-binding peptides from phage display library and computer-aided design on BLyS–TACI interaction, International Immunopharmacology, 2015, 24, 2, 219

    CrossRef

  10. 10
    Anne Davidson, What is damaging the kidney in lupus nephritis?, Nature Reviews Rheumatology, 2015, 12, 3, 143

    CrossRef

  11. 11
    Thomas Dörner, Peter E. Lipsky, B cells, Current Opinion in Rheumatology, 2014, 26, 2, 228

    CrossRef

  12. 12
    J Kimura, O Ichii, T Nakamura, T Horino, S Otsuka, Y Kon, BXSB-type genome causes murine autoimmune glomerulonephritis: pathological correlation between telomeric region of chromosome 1 and Yaa, Genes and Immunity, 2014, 15, 3, 182

    CrossRef

  13. 13
    Ramalingam Bethunaickan, Celine C. Berthier, Weijia Zhang, Ridvan Eksi, Hong-Dong Li, Yuanfang Guan, Matthias Kretzler, Anne Davidson, Identification of Stage-Specific Genes Associated With Lupus Nephritis and Response to Remission Induction in (NZB × NZW)F1 and NZM2410 Mice, Arthritis & Rheumatology, 2014, 66, 8
  14. 14
    Hans-Joachim Anders, Agnes B. Fogo, Immunopathology of lupus nephritis, Seminars in Immunopathology, 2014, 36, 4, 443

    CrossRef

  15. 15
    A David, A Trigunaite, M K MacLeod, A C Johnson, P Marrack, T N Jørgensen, Intrinsic autoimmune capacities of hematopoietic cells from female New Zealand hybrid mice, Genes and Immunity, 2014, 15, 3, 153

    CrossRef

  16. 16
    Georg Lorenz, Jyaysi Desai, Hans-Joachim Anders, Lupus nephritis, Current Opinion in Nephrology and Hypertension, 2014, 23, 3, 211

    CrossRef

  17. 17
    Xiao-juan Zhu, Yan Shi, Feng Zhang, Qing-min Yao, Yan-xia Liu, Ning-ning Shan, Dan Wang, Jun Peng, Jian Xu, Ming Hou, Reduced tumour necrosis factor receptor superfamily 13C inversely correlated with tumour necrosis factor superfamily 13B in patients with immune thrombocytopenia, British Journal of Haematology, 2014, 166, 5
  18. 18
    Ranjit Sahu, Ramalingam Bethunaickan, Satwinder Singh, Anne Davidson, Structure and Function of Renal Macrophages and Dendritic Cells From Lupus-Prone Mice, Arthritis & Rheumatology, 2014, 66, 6
  19. 19
    Yu Tian, Yan-feng Zhu, Zhen Wu, Jian-nan Feng, Yan Li, Bei-fen Shen, Jian Sun, An optimized B lymphocyte stimulator (BLyS) antagonist peptide inhibits the interaction of BLyS with BCMA, Biotechnology Letters, 2013, 35, 4, 523

    CrossRef

  20. 20
    Moncef Zouali, Eugene A. Uy, Belimumab Therapy in Systemic Lupus Erythematosus, BioDrugs, 2013, 27, 3, 225

    CrossRef

  21. 21
    Junpei Kimura, Osamu Ichii, Saori Otsuka, Hayato Sasaki, Yoshiharu Hashimoto, Yasuhiro Kon, Close Relations between Podocyte Injuries and Membranous Proliferative Glomerulonephritis in Autoimmune Murine Models, American Journal of Nephrology, 2013, 38, 1, 27

    CrossRef

  22. 22
    Xin-guang Liu, Ming Hou, Immune Thrombocytopenia and B-Cell-Activating Factor/A Proliferation-Inducing Ligand, Seminars in Hematology, 2013, 50, S89

    CrossRef

  23. 23
    Èlia Ripoll, Ana Merino, Josep M Grinyó, Juan Torras, New approaches for the treatment of lupus nephritis in the 21st century: from the laboratory to the clinic, Immunotherapy, 2013, 5, 10, 1089

    CrossRef

  24. 24
    L. Fernandez, G. F. Salinas, C. Rocha, C. E. Carvalho-Pinto, N. Yeremenko, L. Papon, J. P. Medema, B. Combe, J. Morel, D. Baeten, M. Hahne, The TNF family member APRIL dampens collagen-induced arthritis, Annals of the Rheumatic Diseases, 2013, 72, 8, 1367

    CrossRef

  25. 25
    Ram Raj Singh, Shweta Dubey, Julia Pinkhasov, Dubois' Lupus Erythematosus and Related Syndromes, 2013,

    CrossRef

  26. 26
    Bevra Hannahs Hahn, Dwight Kono, Dubois' Lupus Erythematosus and Related Syndromes, 2013,

    CrossRef

  27. 27
    Ramalingam Bethunaickan, Ranjit Sahu, Zheng Liu, Yi Ting Tang, Weiqing Huang, Osarieman Edegbe, Haiou Tao, Meera Ramanujam, Michael P. Madaio, Anne Davidson, Anti–tumor necrosis factor α treatment of interferon-α–induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation, Arthritis & Rheumatism, 2012, 64, 10
  28. 28
    Worapot Treamtrakanpon, Pornpen Tantivitayakul, Thitima Benjachat, Poorichaya Somparn, Wipawee Kittikowit, Somchai Eiam-ong, Asada Leelahavanichkul, Nattiya Hirankarn, Yingyos Avihingsanon, APRIL, a proliferation-inducing ligand, as a potential marker of lupus nephritis, Arthritis Research & Therapy, 2012, 14, 6, R252

    CrossRef

  29. 29
    A. Thibault-Espitia, Y. Foucher, R. Danger, T. Migone, A. Pallier, S. Castagnet, C. G.-Gueguen, A. Devys, A. C.-Gautier, M. Giral, J.-P. Soulillou, S. Brouard, BAFF and BAFF-R Levels Are Associated With Risk of Long-Term Kidney Graft Dysfunction and Development of Donor-Specific Antibodies, American Journal of Transplantation, 2012, 12, 10
  30. 30
    Onkar P. Kulkarni, Hans-Joachim Anders, Lupus nephritis. How latest insights into its pathogenesis promote novel therapies, Current Opinion in Rheumatology, 2012, 24, 5, 457

    CrossRef

  31. 31
    Matthew M. Seavey, Lily D. Lu, Kristine L. Stump, Nate H. Wallace, Bruce A. Ruggeri, Novel, orally active, proteasome inhibitor, delanzomib (CEP-18770), ameliorates disease symptoms and glomerulonephritis in two preclinical mouse models of SLE, International Immunopharmacology, 2012, 12, 1, 257

    CrossRef

  32. 32
    Allison Sang, Yiming Yin, Ying-Yi Zheng, Laurence Morel, Animal Models of Molecular Pathology, 2012,

    CrossRef

  33. 33
    Ana M Bertoli, Graciela S Alarcón, Immunotherapeutic Agents for SLE, 2012,

    CrossRef

  34. 34
    Laurence Morel, Advances in Immunology Volume 115, 2012,

    CrossRef

  35. 35
    Zheng Liu, Anne Davidson, BAFF and selection of autoreactive B cells, Trends in Immunology, 2011, 32, 8, 388

    CrossRef

  36. 36
    Zheng Liu, Anne Davidson, BAFF inhibition: A new class of drugs for the treatment of autoimmunity, Experimental Cell Research, 2011, 317, 9, 1270

    CrossRef

  37. 37
    Qing-Tong Wang, Yu-Kun Ma, Bei Huang, Dan-Dan Liu, Wei Wei, Effect of rhTACI-Ig fusion protein on antigen-specific T cell responses from keyhole limpet haemocyanin challenged mice, Molecular Immunology, 2011, 49, 1-2, 380

    CrossRef

  38. 38
    G. O. Eilertsen, M. Van Ghelue, H. Strand, J. C. Nossent, Increased levels of BAFF in patients with systemic lupus erythematosus are associated with acute-phase reactants, independent of BAFF genetics: a case-control study, Rheumatology, 2011, 50, 12, 2197

    CrossRef

  39. 39
    Daniel Perry, Allison Sang, Yiming Yin, Ying-Yi Zheng, Laurence Morel, Murine Models of Systemic Lupus Erythematosus, Journal of Biomedicine and Biotechnology, 2011, 2011, 1

    CrossRef

  40. 40
    Harini Bagavant, Kambiz Kalantarinia, Yogesh Scindia, Umesh Deshmukh, Novel Therapeutic Approaches to Lupus Glomerulonephritis: Translating Animal Models to Clinical Practice, American Journal of Kidney Diseases, 2011, 57, 3, 498

    CrossRef

  41. 41
    William Stohl, Jean L Scholz, Michael P Cancro, Targeting BLyS in rheumatic disease: the sometimes-bumpy road from bench to bedside, Current Opinion in Rheumatology, 2011, 23, 3, 305

    CrossRef

  42. 42
    Anne Davidson, Targeting BAFF in autoimmunity, Current Opinion in Immunology, 2010, 22, 6, 732

    CrossRef